Tazarotene Reformulated for the Treatment of Acne

ARAZLO® (tazarotene) Lotion, 0.045% is contraindicated during pregnancy. See additional Important Safety Information at the end of the video.

Dr. Emil A. Tanghetti with the Center for Dermatology and Laser Surgery in Sacramento, California, and Dr. Hilary Baldwin with the Acne Treatment & Research Center and Robert Wood Johnson Medical Center in New Brunswick, New Jersey, discuss what makes ARAZLO® (tazarotene) 0.045% Lotion formulation so unique in the treatment of acne.

Drs. Tanghetti and Baldwin are paid consultants for Bausch Health US, LLC. 

Check out our video “Managing Acne in Adult Women” 

with Emil A. Tanghetti, MD, and Julie C. Harper, MD